|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/18 | |
| A61P 25/02 | |||
| A61P 43/00 | |||
| A61P 15/10 |
| (11) | Number of the document | 3278811 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17187879.6 |
| Date of filing the European patent application | 2013-03-29 | |
| (97) | Date of publication of the European application | 2018-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261618381 P | 2012-03-30 | US | |
| 201261674060 P | 2012-07-20 | US | |
| 201261693589 P | 2012-08-27 | US | |
| 201261693585 P | 2012-08-27 | US | |
| 201361785419 P | 2013-03-14 | US |
| (72) |
CAGGIANO, Anthony, O., US
BELLA, Anthony, J., CA
GANGULY, Anindita, US
IACI, Jennifer, US
PARRY, Thomas, US
COLBURN, Raymond, Warren, US
|
| (73) |
Acorda Therapeutics, Inc.,
420 Saw Mill River Road, Ardsley, NY 10502,
US
|
| (54) | USE OF GGF2 TO TREAT NEUROPATHIC PAIN UPON PERIPHERAL NERVE INJURY |
| USE OF GGF2 TO TREAT NEUROPATHIC PAIN UPON PERIPHERAL NERVE INJURY |